AddLife Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

AddLife wird ein jährliches Gewinn- und Umsatzwachstum von 52% bzw. 5.6% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 51.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 8.4% betragen.

Wichtige Informationen

52.0%

Wachstumsrate der Gewinne

51.9%

EPS-Wachstumsrate

Life Sciences Gewinnwachstum	43.8%
Wachstumsrate der Einnahmen	5.6%
Zukünftige Eigenkapitalrendite	8.4%
Analystenabdeckung	Low
Zuletzt aktualisiert	15 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Update: Here's Why Analysts Just Lifted Their AddLife AB (publ) (STO:ALIF B) Price Target To kr155

Jul 18

AddLife AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models

Feb 07

Recent updates

Does AddLife (STO:ALIF B) Have A Healthy Balance Sheet?

Oct 02

AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

Jul 26

AddLife's (STO:ALIF B) Weak Earnings May Only Reveal A Part Of The Whole Picture

Jul 22

Earnings Update: Here's Why Analysts Just Lifted Their AddLife AB (publ) (STO:ALIF B) Price Target To kr155

Jul 18

Is There An Opportunity With AddLife AB (publ)'s (STO:ALIF B) 43% Undervaluation?

Oct 14

AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Sep 08

Is Now The Time To Look At Buying AddLife AB (publ) (STO:ALIF B)?

Aug 18

Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Jul 05

Is Now An Opportune Moment To Examine AddLife AB (publ) (STO:ALIF B)?

May 18

Is AddLife (STO:ALIF B) Using Too Much Debt?

Apr 28

AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

Apr 05

AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

Feb 21

AddLife (STO:ALIF B) Has Announced That Its Dividend Will Be Reduced To SEK1.20

Feb 07

Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

Jan 20

AddLife (STO:ALIF B) Has A Pretty Healthy Balance Sheet

Dec 30

Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Oct 27

Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

Oct 11

Is AddLife (STO:ALIF B) A Risky Investment?

Sep 23

When Should You Buy AddLife AB (publ) (STO:ALIF B)?

Jul 11

Is AddLife (STO:ALIF B) Using Too Much Debt?

Jun 25

Gewinn- und Umsatzwachstumsprognosen

OM:ALIF B - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (SEK Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
12/31/2026	11,307	525	907	1,305	2
12/31/2025	10,673	444	921	1,325	2
12/31/2024	10,078	246	641	971	2
9/30/2024	10,012	117	587	877	N/A
6/30/2024	9,987	118	574	878	N/A
3/31/2024	9,798	78	461	765	N/A
12/31/2023	9,685	190	465	773	N/A
9/30/2023	9,467	292	386	676	N/A
6/30/2023	9,248	387	274	558	N/A
3/31/2023	8,962	429	393	682	N/A
12/31/2022	9,084	480	628	909	N/A
9/30/2022	8,889	597	715	951	N/A
6/30/2022	8,639	615	957	1,164	N/A
3/31/2022	8,836	718	982	1,158	N/A
12/31/2021	7,993	719	867	1,010	N/A
9/30/2021	7,593	759	1,047	1,176	N/A
6/30/2021	6,984	748	1,006	1,126	N/A
3/31/2021	5,956	690	960	1,054	N/A
12/31/2020	5,273	518	859	950	N/A
9/30/2020	4,530	349	479	566	N/A
6/30/2020	4,091	248	357	444	N/A
3/31/2020	3,687	160	291	381	N/A
12/31/2019	3,479	141	315	400	N/A
9/30/2019	3,176	136	244	318	N/A
6/30/2019	2,952	134	212	274	N/A
3/31/2019	2,730	138	180	238	N/A
12/31/2018	2,482	129	129	178	N/A
9/30/2018	2,465	125	138	182	N/A
6/30/2018	2,404	123	N/A	192	N/A
3/31/2018	2,354	117	N/A	200	N/A
12/31/2017	2,333	120	N/A	208	N/A
9/30/2017	2,277	129	N/A	207	N/A
6/30/2017	2,169	125	N/A	208	N/A
3/31/2017	2,062	122	N/A	165	N/A
12/31/2016	1,939	112	N/A	133	N/A
9/30/2016	1,799	90	N/A	99	N/A
6/30/2016	1,760	82	N/A	99	N/A
3/31/2016	1,562	78	N/A	118	N/A
12/31/2015	1,394	78	N/A	138	N/A
3/31/2015	1,057	80	N/A	120	N/A
3/31/2014	984	78	N/A	92	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: ALIF BDas prognostizierte Gewinnwachstum (52% pro Jahr) liegt über der Sparquote (1.2%).

Ertrag vs. Markt: ALIF BDie Erträge des Unternehmens (52% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (15% pro Jahr).

Hohe Wachstumserträge: ALIF BEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: ALIF BDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Swedish (-0.04% pro Jahr).

Hohe Wachstumseinnahmen: ALIF BDie Einnahmen des Unternehmens (5.6% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: ALIF BDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (8.4%).

AddLife Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Earnings Update: Here's Why Analysts Just Lifted Their AddLife AB (publ) (STO:ALIF B) Price Target To kr155

AddLife AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models

Consensus EPS estimates fall by 19%

Price target decreased by 19% to kr118

Price target decreased by 11% to kr136

Price target increased by 7.4% to kr138

Recent updates

President & CEO recently bought kr1m worth of stock

New minor risk - Earnings quality

Third quarter 2024 earnings: EPS and revenues miss analyst expectations

AddLife AB (publ) to Report First Half, 2025 Results on Jul 15, 2025

Does AddLife (STO:ALIF B) Have A Healthy Balance Sheet?

AddLife AB (publ) (STO:ALIF B) Surges 26% Yet Its Low P/S Is No Reason For Excitement

AddLife's (STO:ALIF B) Weak Earnings May Only Reveal A Part Of The Whole Picture

Earnings Update: Here's Why Analysts Just Lifted Their AddLife AB (publ) (STO:ALIF B) Price Target To kr155

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

AddLife AB (publ) to Report Q1, 2025 Results on Apr 25, 2025

President & CEO recently bought kr856k worth of stock

Insufficient new directors

Revenues Working Against AddLife AB (publ)'s (STO:ALIF B) Share Price

Chief Financial Officer recently bought kr271k worth of stock

AddLife AB (publ) Approves Dividend, Payable on 16 May 2024

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

AddLife AB (publ) to Report Fiscal Year 2024 Results on Feb 05, 2025

Are Investors Undervaluing AddLife AB (publ) (STO:ALIF B) By 42%?

Is It Time To Consider Buying AddLife AB (publ) (STO:ALIF B)?

Independent Director recently bought kr207k worth of stock

Independent Director recently bought kr32m worth of stock

AddLife AB (publ) to Report Fiscal Year 2023 Results on Apr 05, 2024

President & CEO recently bought kr220k worth of stock

AddLife AB (publ) Just Missed Earnings - But Analysts Have Updated Their Models

Full year 2023 earnings: EPS misses analyst expectations

AddLife AB (publ) to Report Q3, 2024 Results on Oct 23, 2024

Consensus EPS estimates fall by 19%

Independent Director recently bought kr521k worth of stock

AddLife AB (publ)'s (STO:ALIF B) 28% Share Price Surge Not Quite Adding Up

AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Is It Too Late To Consider Buying AddLife AB (publ) (STO:ALIF B)?

Investor sentiment improves as stock rises 30%

Chief Financial Officer recently bought kr143k worth of stock

AddLife AB (publ) to Report First Half, 2024 Results on Jul 15, 2024

Third quarter 2023 earnings: Revenues exceed analyst expectations

AddLife AB (publ), Annual General Meeting, May 08, 2024

Price target decreased by 19% to kr118

Is There An Opportunity With AddLife AB (publ)'s (STO:ALIF B) 43% Undervaluation?

New minor risk - Share price stability

Independent Director recently bought kr581k worth of stock

President & CEO recently bought kr208k worth of stock

AddLife (STO:ALIF B) Has A Somewhat Strained Balance Sheet

Is Now The Time To Look At Buying AddLife AB (publ) (STO:ALIF B)?

Independent Chairman recently bought kr1.3m worth of stock

Price target decreased by 11% to kr136

New minor risk - Share price stability

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 23% undervalued after recent price drop

Calculating The Fair Value Of AddLife AB (publ) (STO:ALIF B)

Independent Director recently bought kr12m worth of stock

Is Now An Opportune Moment To Examine AddLife AB (publ) (STO:ALIF B)?

President & CEO recently bought kr129k worth of stock

Addlife AB (Publ) Declares Dividend

Price target increased by 7.4% to kr138

Upcoming dividend of kr1.20 per share at 1.0% yield

Is AddLife (STO:ALIF B) Using Too Much Debt?

First quarter 2023 earnings: Revenues exceed analyst expectations

Investor sentiment improves as stock rises 16%

AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

Consensus EPS estimates fall by 24%

President & CEO recently bought kr139k worth of stock

President & CEO recently bought kr112k worth of stock

AddLife (STO:ALIF B) Is Paying Out Less In Dividends Than Last Year

AddLife (STO:ALIF B) Has Announced That Its Dividend Will Be Reduced To SEK1.20

Full year 2022 earnings released: EPS: kr3.94 (vs kr6.02 in FY 2021)

AddLife AB (publ) Proposes Dividend for the Year Ended December 31, 2022

Should You Think About Buying AddLife AB (publ) (STO:ALIF B) Now?

AddLife (STO:ALIF B) Has A Pretty Healthy Balance Sheet

President & CEO recently bought kr285k worth of stock